Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Thorax”

9,836 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 9,836 results

Testing effectiveness (Phase 2)UnknownNCT03848611
What this trial is testing

CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-small Cell Lung Cancer
AnewPharma 20
Testing effectiveness (Phase 2)Study completedNCT00684099
What this trial is testing

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 70
Not applicableLooking for participantsNCT06833632
What this trial is testing

Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 100
Not applicableEnded earlyNCT02834455
What this trial is testing

Rational Approach to a Unilateral Pleural Effusion2

Who this might be right for
Lung Neoplasms
Simon Reuter 200
Not applicableStudy completedNCT04846985
What this trial is testing

Nutritional Problems in Pallative Cancer

Who this might be right for
Lung CancerPancreatic Cancer
Jens Rikardt Andersen 44
Large-scale testing (Phase 3)Study completedNCT02813785
What this trial is testing

Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 565
Testing effectiveness (Phase 2)Looking for participantsNCT06485544
What this trial is testing

Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial

Who this might be right for
Small Cell Lung Cancer (SCLC)
Tang-Du Hospital 104
Not applicableStudy completedNCT02801409
What this trial is testing

Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery

Who this might be right for
Lung CancerThoracic SurgeryAnesthesia, Epidural+2 more
Peking University First Hospital 400
Not applicableUnknownNCT06086587
What this trial is testing

Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment

Who this might be right for
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 500
Not applicableStudy completedNCT01285648
What this trial is testing

Study of CPAP as Intervention After Lung Resection

Who this might be right for
Lung CancerPulmonary Complications
University of Campinas, Brazil 40
Not applicableStudy completedNCT01662635
What this trial is testing

Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK)

Who this might be right for
Non Small-cell Lung Cancer
Instituto Nacional de Cancerologia de Mexico 230
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Early research (Phase 1)Ended earlyNCT02309892
What this trial is testing

A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Helix BioPharma Corporation 14
Testing effectiveness (Phase 2)Ended earlyNCT01857271
What this trial is testing

Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer
Albert Einstein College of Medicine 3
Testing effectiveness (Phase 2)Study completedNCT05509699
What this trial is testing

Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Hutchison Medipharma Limited 21
Not applicableStudy completedNCT04566614
What this trial is testing

Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies

Who this might be right for
Neoplasm, ColorectalNeoplasm of LungNeoplasm, Bladder+3 more
Royal Marsden NHS Foundation Trust 128
Testing effectiveness (Phase 2)Study completedNCT02568449
What this trial is testing

Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent

Who this might be right for
Recurrent Pleural Malignant MesotheliomaStage IV Pleural Mesothelioma
Barbara Ann Karmanos Cancer Institute 20
Not applicableStudy completedNCT01307085
What this trial is testing

Effect of Remote Ischemic Preconditioning on Lung Injury After Pulmonary Resection

Who this might be right for
Lung Neoplasms
Cai Li 108
Large-scale testing (Phase 3)Active Not RecruitingNCT04380636
What this trial is testing

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 870
Not applicableStudy completedNCT00960271
What this trial is testing

Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
University Hospital, Rouen 363
Load More Results